Exosome Diagnostics isolates exosomes, cell-derived vesicles, which contain RNA, DNA and proteins, from serum, plasma, urine, cerebralspinal fluid and saliva. The company performs molecular analysis of exosomes for diagnotics, disease detection, treatment and monitoring. Exosome Diagnostics collaborates with pharmaceutical companies such as Amgen and Takeda in research and development, biomarker discovery, validation and development of diagnostics.
While Chief Scientific Officer Johan Skog was at Massachusetts General Hospital, he was the first to demonstrate the detection of molecular mutations in a tumor in RNA extracted from exosomes in Nature Cell Biology in 2008.
Founding Scientist, CSO
Mikkel Noerholm, PhD
VP Product Development
Thomas McLain, MBA, CPA
William J. Kelly, CPA
Documentaries, videos and podcasts